NanoTemper (@nanotemper) 's Twitter Profile
NanoTemper

@nanotemper

NanoTemper provides biophysical tools that address challenging characterizations for use in drug discovery and basic science research.

ID: 821737962861948929

linkhttp://www.nanotempertech.com calendar_today18-01-2017 15:16:12

516 Tweet

491 Takipçi

60 Takip Edilen

NanoTemper (@nanotemper) 's Twitter Profile Photo

Thank you to everyone we connected with at #PEGSBoston! It was exciting to chat about ways to de-risk candidate selection with high-resolution stability data on your biologics. #PEGS23

Thank you to everyone we connected with at #PEGSBoston! It was exciting to chat about ways to de-risk candidate selection with high-resolution stability data on your biologics. 

#PEGS23
NanoTemper (@nanotemper) 's Twitter Profile Photo

Thank you all the biologics scientists who visited us at #AntibodyEng! It was exciting to connect and chat about ways to support your biologics developability assessment and candidate selection projects.

Thank you all the biologics scientists who visited us at #AntibodyEng! It was exciting to connect and chat about ways to support your biologics developability assessment and candidate selection projects.
NanoTemper (@nanotemper) 's Twitter Profile Photo

🎉 We’re celebrating 15 years! 🎉 Thank you to our amazing customers and team. We wouldn’t be celebrating this milestone without you. Let’s continue to work towards creating a world where every disease is treatable. #NanoTemperTurns15

🎉 We’re celebrating 15 years! 🎉

Thank you to our amazing customers and team. We wouldn’t be celebrating this milestone without you. Let’s continue to work towards creating a world where every disease is treatable. #NanoTemperTurns15
NanoTemper (@nanotemper) 's Twitter Profile Photo

Biologics researchers — To select candidates with optimal qualities in early development, join Stefanie and learn about which biophysical characteristics to combine for full developability profiling of your biologics. ow.ly/96Rl50OU5kg

Biologics researchers  — To select candidates with optimal qualities in early development, join Stefanie and learn about which biophysical characteristics to combine for full developability profiling of your biologics. 

ow.ly/96Rl50OU5kg
NanoTemper (@nanotemper) 's Twitter Profile Photo

Happy Pride! Today is CSD Munich as part of Munich Pride in our headquarter city. We celebrate and honor the contributions of our LGBTQIA+ team members, customers, and scientific community worldwide. We value and are committed to acceptance and inclusivity — today and every day.

Happy Pride! Today is CSD Munich as part of Munich Pride in our headquarter city. We celebrate and honor the contributions of our LGBTQIA+ team members, customers, and scientific community worldwide. We value and are committed to acceptance and inclusivity — today and every day.
NanoTemper (@nanotemper) 's Twitter Profile Photo

It’s #ThrowbackThursday! These past 15 years have been unforgettable. Take a look back at some photos from our early days. 📷 #NanoTemperTurns15

It’s #ThrowbackThursday! These past 15 years have been unforgettable. Take a look back at some photos from our early days. 📷 

#NanoTemperTurns15
NanoTemper (@nanotemper) 's Twitter Profile Photo

We’re celebrating a big milestone: 15 years of working with incredible customers dedicated to creating a world where every disease is treatable. Thank you to all our customers for making this milestone possible. 🎉 #NanoTemperTurns15

We’re celebrating a big milestone: 15 years of working with incredible customers dedicated to creating a world where every disease is treatable. Thank you to all our customers for making this milestone possible. 🎉 

#NanoTemperTurns15
NanoTemper (@nanotemper) 's Twitter Profile Photo

We had a blast at our 15th anniversary party. Thank you to our team and their families, our friends, and our customers who helped us celebrate. You made this 15 year milestone possible. Cheers to the journey ahead! #NanoTemperTurns15

We had a blast at our 15th anniversary party. Thank you to our team and their families, our friends, and our customers who helped us celebrate. You made this 15 year milestone possible. Cheers to the journey ahead!

#NanoTemperTurns15
NanoTemper (@nanotemper) 's Twitter Profile Photo

Biologics researchers - Do you know which biophysical characteristics to combine for a full developability profile of your candidates? Watch this video and learn how Merck’s team approaches candidate selection in early development. bit.ly/44OVtVR

NanoTemper (@nanotemper) 's Twitter Profile Photo

To save time and material during biologics developability assessment, start with stability studies. Read this blog to learn how and which stability characterization parameters help you create developability profiles. bit.ly/3rzo82T

NanoTemper (@nanotemper) 's Twitter Profile Photo

We showed our team spirit at B2Run, joining 30,000 runners from other companies in Munich. The NanoTemper team was happy to be #activetogether. Congrats to everyone who participated! 🏃‍♀️🏃‍♂️🎉

We showed our team spirit at B2Run, joining 30,000 runners from other companies in Munich. The NanoTemper team was happy to be #activetogether. Congrats to everyone who participated! 🏃‍♀️🏃‍♂️🎉
NanoTemper (@nanotemper) 's Twitter Profile Photo

Learn how scientists from University of Manitoba, McGill University, and Repare Therapeutics use biophysical tools for their protein characterization projects to overcome challenges like high-sample consumption and complex assay setup. Register now: ow.ly/7mVx50PMZKF

Learn how scientists from <a href="/umanitoba/">University of Manitoba</a>, <a href="/mcgillu/">McGill University</a>, and <a href="/RepareRx/">Repare Therapeutics</a> use biophysical tools for their protein characterization projects to overcome challenges like high-sample consumption and complex assay setup. 

Register now: ow.ly/7mVx50PMZKF
NanoTemper (@nanotemper) 's Twitter Profile Photo

Join the upcoming webinar to learn how CALIXAR and Curve Therapeutics successfully characterize challenging interactions with IDPs, GPCRs, and other tricky targets. Register now: webinars.on24.com/nanotemper/suc…

Join the upcoming webinar to learn how <a href="/_Calixar/">CALIXAR</a> and Curve Therapeutics successfully characterize challenging interactions with IDPs, GPCRs, and other tricky targets. 

Register now: webinars.on24.com/nanotemper/suc…
NanoTemper (@nanotemper) 's Twitter Profile Photo

Thank you to everyone who visited us at Discovery on Target! It was exciting to meet so many scientists working towards removing the meaning of the word “undruggable." Thanks for connecting and chatting about ways to support your screening projects. #BostonDOT23

Thank you to everyone who visited us at Discovery on Target! It was exciting to meet so many scientists working towards removing the meaning of the word “undruggable." Thanks for connecting and chatting about ways to support your screening projects. 

#BostonDOT23
NanoTemper (@nanotemper) 's Twitter Profile Photo

The ELRIG Drug Discovery is around the corner! If you’re attending the Hit ID and Screening track, stop by booth #C31 to chat about new technologies to tackle challenging affinity screening projects! #DrugDiscovery2023

The <a href="/ELRIG_UK/">ELRIG</a> Drug Discovery is around the corner! If you’re attending the Hit ID and Screening track, stop by booth #C31 to chat about new technologies to tackle challenging affinity screening projects!

#DrugDiscovery2023
NanoTemper (@nanotemper) 's Twitter Profile Photo

Thank you to all the biologics scientists who visited us at Festival of Biologics in Basel! It was exciting to connect and chat about ways to support your biologics developability assessment and candidate selection projects. #FestivalofBiologics

Thank you to all the biologics scientists who visited us at Festival of Biologics in Basel! It was exciting to connect and chat about ways to support your biologics developability assessment and candidate selection projects.

#FestivalofBiologics
NanoTemper (@nanotemper) 's Twitter Profile Photo

Join this webinar to learn how to measure binding affinities with low sample consumption and no immobilization requirements using Spectral Shift — the go-to technology for in-solution measurements in countless buffers. Register now: ow.ly/r5Fi50PWh4T

Join this webinar to learn how to measure binding affinities with low sample consumption and no immobilization requirements using Spectral Shift — the go-to technology for in-solution measurements in countless buffers.

Register now: ow.ly/r5Fi50PWh4T
NanoTemper (@nanotemper) 's Twitter Profile Photo

Thank you to all the scientists who connected with us at ELRIG Drug Discovery! It was exciting to hear about your affinity screening projects and discuss ways to support them. #DrugDiscovery2023

Thank you to all the scientists who connected with us at ELRIG Drug Discovery! It was exciting to hear about your affinity screening projects and discuss ways to support them.

#DrugDiscovery2023
NanoTemper (@nanotemper) 's Twitter Profile Photo

Our original global headquarters will always hold a special place in our hearts. Let’s take a look back at some of our favorite memories 📷 before we officially open our new office. NanoTemper team, what’s your favorite memory at WerkStadt Sendling?

Our original global headquarters will always hold a special place in our hearts. Let’s take a look back at some of our favorite memories 📷 before we officially open our new office.

NanoTemper team, what’s your favorite memory at WerkStadt Sendling?